Whitehawk Therapeutics (WHWK) Other Non-Current Assets (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 11 years of Other Non-Current Assets data on file, last reported at $1.7 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $1.7 million, up 23.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 23.33% YoY), and the FY2025 annual result was $1.8 million, up 29.66% from the prior year.
• Other Non-Current Assets fell to $1.7 million in Q1 2026 per WHWK's latest filing, from $1.8 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.3 million in Q1 2022 and troughed at $1.4 million in Q1 2025.
• A 5-year average of $1.9 million and a median of $1.9 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 11585.0% in 2022, then retreated 25.03% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $2.2 million in 2022, then dropped by 14.33% to $1.9 million in 2023, then dropped by 25.03% to $1.4 million in 2024, then increased by 29.66% to $1.8 million in 2025, then fell by 7.33% to $1.7 million in 2026.
• Business Quant data shows WHWK's Other Non-Current Assets at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $2.0 million in Q3 2025.